Skip to Content

ResMed renews patent battle with F&P

ResMed renews patent battle with F&P

SAN DIEGO - ResMed has filed a new petition with the U.S. International Trade Commission to stop the alleged infringement of its patented technology by New Zealand-based Fisher & Paykel Healthcare. ResMed seeks an order banning the importation and sale in the U.S. of F&P's Simplus full-face mask, Eson nasal mask and Eson 2 nasal mask for allegedly infringing five ResMed patents related to mask system and cushion design. ResMed has also filed a new lawsuit in the U.S. District Court for the Southern District of California seeking monetary damages, plus an infringement against future sales. F&P, which will contest the allegations, has cut its fiscal year 2019 net profit outlook due to expected legal expenses, according to news reports.

Comments

To comment on this post, please log in to your account or set up an account now.